secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nkarta, Inc. (NKTX)
CIK:        0001787400
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0000950170-23-010937
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nkarta CFO Nadir Mahmood resigns effective June 30, 2023; clinical timelines reaffirmed
--------------------------------------------------------------------------------

- CFO Nadir Mahmood resigns to become CEO of a private biotech; effective June 30, 2023.
- Nkarta initiates external search for new CFO.
- NKX101 clinical update on track for Q2 2023; NKX019 update expected in full year 2023.
- Mahmood will remain until June 30 to ensure smooth transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787400/000095017023010937/0000950170-23-010937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787400/000095017023010937/nktx-20230328.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-010937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer